Table 3 Timing and durability of symptom improvement
Domain | Median time to improve (mo.) | Range (mo.) | Durability of improve* | Median time to worsening (mo.) (range) | Range (mo.) |
|---|---|---|---|---|---|
Visual Acuity/Field | 3.2 | 0.1 - 30.1 | 92.7% | 25.0 | 0.2 - 98.2 |
Diplopia/Ptosis | 4.6 | 0.6 - 128.7 | 88.2% | 47.0 | 0.5 - 85.9 |
Facial Sensation | 4.8 | 0.6 - 58.6 | 93.3% | 17.3 | 2.5 - 102.7 |
Facial Weakness | 16.8 | 1.1 - 42.8 | 100% | 33.3 | 1.9 - 64.9 |
Hearing | -- | 2.1 - 2.7 | -- | 5.1 | 2.5 - 82.8 |
Balance | 2.4 | 2.8 - 2.8 | 100% | 11.1 | 2.8 - 114.0 |
Tinnitus | 2.8 | 100% | 3.5 | 2.4 - 4.6 | |
Cranial Nerve IX-XII | 4.9 | 4.2 - 5.6 | 100% | 24.6 | 6.4 - 31.5 |
Other | 2.4 | 0.5 - 5.6 | 91.7% | 9.5 | 2.4 - 20.3 |